|
|
|
| 
|
|
|
My Recent Searches
|
|
|
|
|
|
|
|
|
|
Juno Therapeutics, Inc. (JUNO) |
|
|
$0.00 0.00 (0.00%) as of 4:30 Fri 2/14
|
|
Download |
|
| |
Company
Roster
|
|
Total
Insiders : |
18 |
|
|
|
Total
Direct Shares :
|
11,853,307 |
|
|
Total
Indirect Shares :
|
35,297,598 |
| |
%
Held by Insiders:
|
10.45% |
|
|
| |
| Filer's Name |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
  Pien Howard H |
Director |
2018-03-05 |
0 |
|
0 |
| Barron Hal |
Director |
2018-03-05 |
0 |
2014-12-23 |
0 |
| Cassidy Bernard J |
General Counsel & Secretary |
2018-03-05 |
0 |
2018-03-05 |
0 |
| Azelby Robert |
EVP & Chief Commercial Officer |
2018-03-05 |
0 |
2015-11-01 |
0 |
| Lee Ann L. |
EVP, Technical Operations |
2018-03-05 |
0 |
2017-11-25 |
0 |
| Nelsen Robert |
Director |
2018-03-05 |
0 |
2018-03-05 |
0 |
| Klausner Richard |
Director |
2018-03-05 |
0 |
|
0 |
| Harr Steve |
CFO & Head, Corp. Development |
2018-03-05 |
0 |
|
0 |
| Bishop Hans Edgar |
CEO & President, Director |
2018-03-05 |
0 |
|
0 |
| Agarwal Sunil |
President of R & D |
2018-03-05 |
0 |
2017-04-13 |
0 |
| Evnin Anthony B |
Director |
2018-02-14 |
0 |
2015-07-27 |
0 |
| Levitsky Hyam |
EVP, Research & CSO |
2017-02-07 |
131,334 |
2015-05-28 |
0 |
| Bybee Clinton |
10% Owner |
2016-03-15 |
10,552,390 |
|
0 |
| Frohlich Mark W |
See Remarks |
2016-02-29 |
919,583 |
|
0 |
| Bratton Douglas K |
10% Owner |
2015-06-23 |
0 |
2015-07-02 |
25,948,799 |
| Tessier-Lavigne Marc |
Director |
2014-12-23 |
250,000 |
|
0 |
| Cl Alaska, L.p. |
10% Owner |
|
0 |
2017-07-13 |
9,348,799 |
| Flatley Jay T |
Director |
|
0 |
2018-03-05 |
0 |
|
|
